Suppr超能文献

针对同基因鼠肿瘤具有反应性的细胞毒性T淋巴细胞及其特异性抑制性T细胞均由体外同种致敏诱导产生。

Cytotoxic T lymphocytes reactive against a syngeneic murine tumor and their specific suppressor T cells are both elicited by in vitro allosensitization.

作者信息

Leshem B, Kedar E

机构信息

Lautenberg Center for General and Tumor Immunology, Hebrew University-Hadassah Medical School, Jerusalem, Israel.

出版信息

J Exp Med. 1990 Apr 1;171(4):1057-71. doi: 10.1084/jem.171.4.1057.

Abstract

Sensitization of C57BL/6 (B6, H-2b) splenocytes against normal BALB/c (H-2d) leukocytes (B6 a/BALB) in bulk MLC induced CTL reactive against the syngeneic (H-2b) nonimmunogenic lymphoma PIR-2, in addition to the CTL directed against the corresponding (H-2d) allotargets. However, MLC-derived lymphocytes did not directly exhibit anti-PIR-2 cytotoxicity in spite of the high anti-PIR-2 CTL frequency (up to 1/20) among them, as demonstrated by the limiting dilution culture (LDC) technique. The present study was undertaken to resolve this contradiction. We found that anti-PIR-2 cytotoxicity could be detected only when B6 a/BALB MLC-derived responding cells were plated in LDC at low numbers (less than 200) of cells/well. In contrast, increasing the number of the plated cells to 500-5,000 resulted in a gradual decrease in the percentage of wells cytotoxically reactive against PIR-2, whereas the percentage of wells exhibiting cytotoxicity against the allotargets remained unchanged (100%). This decrease of anti-PIR-2 cytotoxicity in LDC and the lack of anti-PIR-2 reactivity among MLC-derived lymphocytes were shown by mixing experiments to result from the activity of radioresistant Thy-1+, Lyt-2+, L3T4- suppressor cells, blocking the anti-PIR-2 cytotoxicity at the effector phase. The suppression was specific as indicated by the following observations: (a) freshly obtained B6 splenocytes, cultured unsensitized B6 splenocytes, mitogen-induced B6 lymphoblasts, B6 LAK cells, or B6 a/B6 MLC-derived lymphocytes were not suppressive; (b) anti-PIR-2 cytotoxicity elicited in B6 a/BALB LDC was suppressed only by lymphocytes derived from B6 a/BALB MLC and not from B6 a/C3H (H-2k) MLC; and (c) B6 a/BALB MLC-induced suppressor cells could be adsorbed on monolayers of BALB/c but not of C3H lymphoblasts. Since both syngeneic tumor and allogeneic target cells were lysed by the same clonal cell population but only the antisyngeneic activity was suppressed, we suggest that a single CTL can exhibit two cytotoxic activities that are differentially affected by the described suppressor cells. This mode of suppression may play a role in controlling autoimmune reactivity.

摘要

在大量混合淋巴细胞培养(MLC)中,用正常BALB/c(H-2d)白细胞致敏C57BL/6(B6,H-2b)脾细胞(B6 a/BALB),除了诱导针对相应(H-2d)异基因靶标的CTL外,还诱导出了针对同基因(H-2b)非免疫原性淋巴瘤PIR-2的CTL。然而,尽管通过有限稀释培养(LDC)技术证明其中抗PIR-2 CTL频率很高(高达1/20),但MLC来源的淋巴细胞并未直接表现出抗PIR-2细胞毒性。本研究旨在解决这一矛盾。我们发现,只有当将B6 a/BALB MLC来源的反应细胞以低细胞数(每孔少于200个细胞)接种到LDC中时,才能检测到抗PIR-2细胞毒性。相反,将接种细胞数增加到500 - 5000个,导致对PIR-2具有细胞毒性反应的孔的百分比逐渐降低,而对异基因靶标具有细胞毒性的孔的百分比保持不变(100%)。混合实验表明,LDC中抗PIR-2细胞毒性的降低以及MLC来源的淋巴细胞中缺乏抗PIR-2反应性是由辐射抗性的Thy-1 +、Lyt-2 +、L3T4 - 抑制细胞的活性导致的,这些抑制细胞在效应阶段阻断了抗PIR-2细胞毒性。如下观察结果表明这种抑制具有特异性:(a)新鲜获得的B6脾细胞、未致敏培养的B6脾细胞、丝裂原诱导的B6淋巴母细胞、B6 LAK细胞或B6 a/B6 MLC来源的淋巴细胞均无抑制作用;(b)B6 a/BALB LDC中诱导的抗PIR-2细胞毒性仅被B6 a/BALB MLC来源的淋巴细胞抑制,而不被B6 a/C3H(H-2k)MLC来源的淋巴细胞抑制;(c)B6 a/BALB MLC诱导的抑制细胞可被BALB/c但不能被C3H淋巴母细胞单层吸附。由于同基因肿瘤细胞和异基因靶细胞都被同一克隆细胞群体裂解,但只有抗同基因活性受到抑制,我们认为单个CTL可以表现出两种细胞毒性活性,而上述抑制细胞对它们的影响不同。这种抑制模式可能在控制自身免疫反应中起作用。

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验